Search results
Results from the WOW.Com Content Network
Contrast-enhanced ultrasound (CEUS) is the application of ultrasound contrast medium to traditional medical sonography. Ultrasound contrast agents rely on the different ways in which sound waves are reflected from interfaces between substances. This may be the surface of a small air bubble or a more complex structure.
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. [1] Contrast agents absorb or alter external electromagnetism or ultrasound , which is different from radiopharmaceuticals , which emit radiation themselves.
Pages in category "Ultrasound contrast agents" The following 2 pages are in this category, out of 2 total. This list may not reflect recent changes. P.
Ultrasound Contrast Agents: Approved in the US and Europe [8] [28] [9] [29] C 4 F 10-1.9: Bubble: Perfluorobutane: Sonazoid: Daiichi Sankyo: Ultrasound Contrast Agent: Approved in Japan, [10] available in Korea, Norway, Taiwan, and China [30] C 5 F 12: 29: Bubble and/or Droplet: Dodecafluoropentane Emulsion, DDFPe: NanO 2, NVX-108, NVX-208 ...
They are used in medical diagnostics as a contrast agent for ultrasound imaging. [4] The gas-filled microbubbles, typically air or perfluorocarbon, oscillate, and vibrate if a sonic energy field is applied and may reflect ultrasound waves. This distinguishes the microbubbles from surrounding tissues.
Ultrasound contrast agents are particles used in ultrasound scans to improve image contrast. The first reported use of an ultrasound contrast agent was by Dr. Raymond Gramiak and Pravin Shah in 1968, when they injected saline into the aortic root of the heart and observed increased contrast. [11]
Ultrasound contrast agents (2 P) Pages in category "Contrast agents" The following 5 pages are in this category, out of 5 total.
The Molecular Imaging and Contrast Agent Database or MICAD is a freely accessible online source of information on in vivo molecular imaging agents. It was established as a key component of the "Molecular Libraries and Imaging" program of the NIH Roadmap, a set of major inter-agency initiatives accelerating medical research and the development of new, more specific therapies for a wide range of ...